Dare Bioscience Holds Annual Stockholder Meeting
Ticker: DARE · Form: 8-K · Filed: Jun 7, 2024 · CIK: 1401914
Sentiment: neutral
Topics: annual-meeting, stockholder-vote, corporate-governance
TL;DR
DARE held its annual meeting, shareholders voted on directors and auditors.
AI Summary
On June 5, 2024, Dare Bioscience, Inc. filed an 8-K report to announce the results of its annual meeting of stockholders. The company's stockholders voted on several proposals, including the election of directors and the ratification of the appointment of its independent registered public accounting firm.
Why It Matters
The outcome of this meeting is important for shareholders as it determines the company's leadership and oversight for the upcoming year.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of annual meeting results and does not introduce new financial or operational risks.
Key Players & Entities
- Dare Bioscience, Inc. (company) — Registrant
- June 5, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 3655 Nobel Drive, Suite 260, San Diego, CA 92122 (address) — Principal Executive Offices
FAQ
What was the primary purpose of the June 5, 2024 8-K filing by Dare Bioscience, Inc.?
The primary purpose was to report the results of the company's annual meeting of stockholders.
What specific items were voted on at the annual meeting of stockholders?
The filing indicates that stockholders voted on proposals including the election of directors and the ratification of the appointment of the independent registered public accounting firm.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 5, 2024.
What is Dare Bioscience, Inc.'s state of incorporation?
Dare Bioscience, Inc. is incorporated in Delaware.
Where are Dare Bioscience, Inc.'s principal executive offices located?
Dare Bioscience, Inc.'s principal executive offices are located at 3655 Nobel Drive, Suite 260, San Diego, CA 92122.
Filing Stats: 774 words · 3 min read · ~3 pages · Grade level 11.3 · Accepted 2024-06-07 16:05:32
Filing Documents
- form8-k.htm (8-K) — 63KB
- 0001493152-24-023097.txt ( ) — 235KB
- dare-20240605.xsd (EX-101.SCH) — 3KB
- dare-20240605_lab.xml (EX-101.LAB) — 33KB
- dare-20240605_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DAR BIOSCIENCE, INC. Dated: June 7, 2024 By: /s/ Sabrina Martucci Johnson Name: Sabrina Martucci Johnson Title: President and Chief Executive Officer -3-